B
Evidence Grade B
Trusted with Context
Current
18%
18% — reduction rate for GLP-1 drugs (2026)
Source:
View source
Curated by Aaron Agius
· Founder, Louder Online
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
18%
Unit
Percentage
Data Vintage
2026
Entity
Sample Size
333,000
Study Type
Unknown
Trend
Stable
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Source
forbes.com
Primary
Tier A
https://www.forbes.com/sites/joshuacohen/2026/04/02/glp-1-discontinuation-by-diabetes-patients-rever… ↗
Original Research
British Medical Journal
· Original study ↗
Methodology
Study tracked patients with type 2 diabetes over three years.
Study: Unknown
Cite this stat
Plain Text
GLP-1 drugs: 18% reduction rate. Source: forbes.com (2026). Via Lighthouse Research Data — https://lighthousedata.io/data/glp-1-cardiovascular-protection-reduction
HTML Embed
<blockquote cite="https://lighthousedata.io/data/glp-1-cardiovascular-protection-reduction" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>18%</strong> — reduction rate for GLP-1 drugs<br><small>Source: forbes.com (2026) · <a href="https://lighthousedata.io/data/glp-1-cardiovascular-protection-reduction" target="_blank" rel="noopener">Lighthouse Data</a></small></blockquote>
Share
Related Statistics
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics — all free.